Pulmonary hypertension due to left heart disease;Pulmonale Hypertonie bei Linksherzerkrankungen

Deutsche Medizinische Wochenschrift

Volumn 135, Issue SUPPL. 3, 2010, Pages

  Rosenkranz, Stephan ^a   Bonderman, D ^b   Buerke, M ^c   Felgendreher, R ^d   Ten Freyhaus, H ^a   Grunig E ^e   De Haan, F ^f   Hammerstingl, C ^g   Harreuter, A ^h   Hohenforst Schmidt, W ⁱ   Kindermann, I ^j   Kindermann, M ^j   Kleber, F X ^h   Kuckeland, M ^k   Kubler W M ^l   Mertens, D ^m   Mitrovic, V ⁿ   Opitz, C ^o   Schmeisser, A ^p   Schulz, U ^q   Speich, R ^r   Zeh, W ^s   Weil, J ^t   more..

^a UNIVERSITY OF COLOGNE   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d KLINIKUM LIPPE DETMOLD   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f Kardiologische Praxis   (Germany)

^g UNIVERSITY HOSPITAL BONN   (Germany)

^h KLINIKUM ERNST VON BERGMANN   (Germany)

ⁱ KLINIKUM COBURG   (Germany)

^j SAARLAND UNIVERSITY   (Germany)

^k Schüchtermannklinik   (Germany)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

ⁿ KERCKHOFF HEART CENTER   (Germany)

^o German Red Cross Hospital   (Germany)

^p UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^q RUHR UNIVERSITY BOCHUM   (Germany)

^r UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^s Department of Angiology   (Germany)

^t UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

more..

Author keywords

heart failure; left heart disease; PAH; PH; pulmonary arterial hypertension; pulmonary hypertension

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

CONFERENCE PAPER; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; HEART DISEASE; HEART FAILURE; HUMAN; PROGNOSIS; PULMONARY HYPERTENSION; CONSENSUS DEVELOPMENT; GERMANY; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; MORTALITY; PHYSIOLOGY; PRACTICE GUIDELINE; SURVIVAL;

GERMANY; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; PROGNOSIS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77957336900     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0030-1263317     Document Type: Conference Paper

References (61)

1. Abramson S V., Burke J F., Kelly Jr J J. et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992 116 888-895
2. Alaeddini J, Uber P A., Park M H., Scott R L., Ventura H O., Mehra M R. Efficacy and safety of sildenafil in the evaluation of pulmonary hypertension in severe heart failure. Am J Cardiol 2004 94 1475-1477 (Pubitemid 39556232)
3. Anand I, McMurray J, Cohn J N., et al, EARTH investigators. Long-term effects of darusentan on left ventricular remodeling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomized, double-blind, placebo-controlled trial. Lancet 2004 364 437-354
4. Aurigemma G P., Gaasch W H. Clinical practice. Diastolic heart failure. N Engl J Med 2004 351 1097-1105
5. Badesch B D., Champion H C., Gomez-Sanchez M A., Hoeper M, Loyd J, Manes A, McGoon M, Naeije R, Olschewski H, Oudiz R, Torbicki A. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009 54 S55-S56
6. Barst R J., Rubin L J., Long W A. et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996 334 296-302
7. Behling A, Rohde L E., Colombo F C., Goldraich L A., Stein R, Clausell N. Effects of 5?-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. J Cardiac Fail 2008 14 189-197 (Pubitemid 351444866)
8. Califf R M., Adams K F., McKenna W J., Gheorghiade M, Uretsky B F., McNulty S E., Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell Jr F E., Wheeler W, Soler-Soler J, Swedberg K. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997 134 44-54 (Pubitemid 27329022)
9. Cappola T P., Felker G M., Kao W H., Hare J M., Baughman K L., Kasper E K. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 2002 105 1663-1668
10. Chang P P., Longenecker J C., Wang N Y., Baughman K L., Conte J V., Hare J M., Kasper E K. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality. J Heart Lung Transplant 2005 24 998-1007
11. Costanzo M R., Augustine S, Bourge R, Bristow M, OConnell J B., Driscoll D, Rose E. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995 92 3593-3612
12. Costard-Jackle A, Fowler M B. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992 19 48-54
13. Davidson C J., Fishman R F., Bonow R O. Cardiac catheterization. In: Libby P, Bonow RO, Mann DL (Eds.) Braunwalds Heart Disease. 8th ed. 2007 177-203
14. De Groote P, Millaire A, Foucher-Hossein C, Nugue O, Marchandise X, Ducloux G, Lablanche J M. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998 32 948-954 (Pubitemid 28459583)
15. Delgado J F. The right heart and pulmonary circulation (III): The pulmonary circulation in heart failure. Rev Esp Cardiol 2010 63 334-345
16. Delgado J F., Conde E, Sanchez V, Lopez-Rios F, Gomez-Sanchez M A., Escribano P, Sotelo T, Gomez de la Camara A, Cortina J, de la Calzada C S. Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 2005 7 1011-1016 (Pubitemid 41443595)
17. ESC Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray J JV, Ponikowski P, Poole-Wilson P A., Stromberg A, van Veldhuisen D J., Atar D, Hoes A W., Keren A, Mebazaa A, Nieminen M, Priori S G., Swedberg K, ESC Committee for Practice Guidelines (CPG), Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen S D., McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano J L. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008 29 2388-2442
18. Faggiano P, Antonini-Canterin F, Ribichini F et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol 2000 85 204-208 (Pubitemid 30026103)
19. Fisher M R., Forfia P R., Chamera E et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009 179 615-621
20. Gali N, Hoeper M M., Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009 30 2493-2537
21. Galie N, Hoeper M M., Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Respir J 2009 34 1219-1263
22. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001 37 183-188 (Pubitemid 32051736)
23. Gnaegi A, Feihl F, Perret C. Intensive care physicians insufficient knowledge of right-heart catheterization at the bedside: time to act? Crit Care Med 1997 25 213-220 (Pubitemid 27086052)
24. Grigioni F, Potena L, Galie N, Fallani F, Bigliardi M, Coccolo F, Magnani G, Manes A, Barbieri A, Fucili A, Magelli C, Branzi A. Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. J Heart Lung Transplant 2006 25 1241-1246 (Pubitemid 44528289)
25. Guazzi M, Guazzi M D. Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients. Clin Pharmacol Ther 2008 83 336-341
26. Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi M D. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol 2007 50 2136-2144 (Pubitemid 350117342)
27. Guazzi M, Tumminello G, Di Marco F, Fiorentini C, Guazzi M D. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 2004 44 2339-2348 (Pubitemid 39647608)
28. Halpern S D., Taichman D B. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009 136 37-43
29. Haraldsson A, Kieler-Jensen N, Ricksten S. The additive pulmonary vasodilator effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension. Anesth Analg 2001 93 1439-1445 (Pubitemid 33111666)
30. Hoeper M, Barbera J A., Channick R, Hassoun P M., Lang I, Manes A, Martinez F, Naeije R, Olschewski H, Pepke-Zaba J, Redfield M, Robbins I, Souza R, Torbicki A, McGoon M. Diagnosis, assessment, and treatment of non-PAH pulmonary hypertension. J Am Coll Cardiol 2009 54 S85-S96 (Pubitemid 38759716)
31. Hoeper M M., Ghofrani H A., Gorenflo M, Grünig E, Schranz D, Rosenkranz S. Diagnostik und Therapie der pulmonalen Hypertonie: Europäische Leitlinien 2009. Pneumologie 2010 64 401-414
32. Jacka M J., Cohen M M., To T, Devitt J H., Byrick R. Pulmonary artery occlusion pressure estimation: how confident are anesthesiologists? Crit Care Med 2002 30 1197-1203 (Pubitemid 34620958)
33. Kalra P R., Moon J C., Coats A J. Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? Int J Cardiol 2002 85 195-197
34. Kjaergaard J, Akkan D, Iversen K K., Kjoller E, Kober L, Torp-Pedersen C, Hassager C. Prognostic importance of pulmonary hypertension in patients with heart failure. Am J Cardiol 2007 99 1146-1150 (Pubitemid 46578202)
35. Kovac G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects. A systematic review. Eur Respir J 2009 34 888-894
36. Kuznetsova T, Herbots L, Lpez B, Jin Y, Richart T, Thijs L, Gonzlez A, Herregods M C., Fagard R H., Dez J, Staessen J A. Prevalence of left ventricular diastolic dysfunction in the general population. Circ Heart Fail 2009 2 105-112
37. Lam C S., Roger V L., Rodeheffer R J., Borlaug B A., Enders F T., Redfield M M. Pulmonary hypertension in heart failure with preserved ejection fraction. J Am Coll Cardiol 2009 53 1119-1126
38. Leuchte H H., Baumgartner R A., Nounou M E. et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006 173 744-750
39. Lewis G D., Lachmann J, Camuso J, Lepore J J., Shin J, Martinovic M E., Systrom D M., Bloch K D., Semigran M J. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007 115 59-66 (Pubitemid 46058612)
40. Lewis G D., Shah R, Shahzad K, Camuso J M., Pappagianopoulos P P., Hung J, Tawakol A, Gerszten R E., Systrom D M., Bloch K D., Semigran M J. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007 116 1555-1562 (Pubitemid 47511419)
41. Luscher T F., Enseleit F, Pacher R, Mitrovic V, Schulze M R., Willenbrock R et al. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure (ET(A) Receptor Blockade Trial (HEAT). Circulation 2002 106 2666-2672 (Pubitemid 35364920)
42. Mc Laughlin V V., Archer S L., Badesch D B. et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009 53 1573-1619
43. Mehra M R., Kobashigawa J, Starling R, Russell S, Uber P A., Parameshwar J et al. Listing criteria for heart transplantation: International society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates 2006. J Heart Lung Transplant 2006 25 1024-1042 (Pubitemid 44311532)
44. Moraes D L., Colucci W S., Givertz M M. Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 2000 102 1718-1723
45. Morris A H., Chapman R H., Gardner R M. Frequency of technical problems encountered in the measurement of pulmonary artery wedge pressure. Crit Care Med 1984 12 164-170 (Pubitemid 14163284)
46. Nagendran J, Archer S L., Soliman D et al. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility. Circulation 2007 116 238-248 (Pubitemid 47196559)
47. Oudiz R J. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med 2007 28 233-241 (Pubitemid 46350735)
48. Packer M, Carver J R., Rodeheffer R J. et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991 325 1468-1475
49. Packer M, McMurray J, Massie B M., Caspi A, Charlon V, Cohen-Solal A, Kiowski W, Kostuk W, Krum H, Levine B, Rizzon P, Soler J, Swedberg K, Anderson S, Demets D L. Clinical effects of endothelin receptor antagonism with bosentan in patients with severe chronic heart failure: results of a pilot study. J Card Fail 2005 11 12-20 (Pubitemid 40215308)
50. Paulus W J., Tschope C, Sanderson J E., Rusconi C, Flachskampf F A., Rademakers F E., Marino P, Smiseth O A., De Keulenaer G, Leite-Moreira A F., Borbely A, Edes I, Handoko M L., Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser A G., Brutsaert D L. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007 28 2539-2550 (Pubitemid 47614269)
51. Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure (RELAX). 2010. Available at: www.clinicaltrials.gov
52. Rich S, McLaughlin V V. Endothelin receptor blockers in cardiovascular disease. Circulation 2003 108 2184-2190 (Pubitemid 37363032)
53. Roques F, Nashef S A., Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones M T., Pintor P P., Salamon R, Thulin L. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999 15 816-822 (Pubitemid 29331957)
54. Rudski L G., Lai W W., Afilalo J, Hua L, Handschumacher M D., Chandrasekaran K, Solomon S D., Louie E K., Schiller N B. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. Am Soc Echocardiogr 2010 23 685-713
55. Sablotzki A, Czeslick E, Schubert S et al. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. Can J Anaesth 2002 49 1076-1080 (Pubitemid 36231109)
56. Semigran M J., Cockrill B A., Kacmarek R et al. Hemodynamic effects of inhaled nitric oxide in heart failure. J Am Coll Cardiol 1994 24 982-988 (Pubitemid 24306408)
57. Simonneau G, Robbins I M., Beghetti M, Channick R N., Delcroix M, Denton C P., Elliott C G., Gaine S P., Gladwin M T., Jing Z -C, Krowka M J., Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009 54 S43-S54
58. Torre-Amione G, Young J B., Colucci W S., Lewis B S., Pratt C, Cotter G et al. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2003 42 140-147 (Pubitemid 36760775)
59. Tribouilloy C, Rusinaru D, Mahjoub H, Soulire V, Lévy F, Peltier M, Slama M, Massy Z. Prognosis of heart failure with preserved efection fraction: a 5 year prospective population-based study. Eur Heart J 2008 29 339-347 (Pubitemid 351197754)
60. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A, Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007 28 230-268 (Pubitemid 46276943)
61. Zanchetti A, Cuspidi C, Comarella L, Rosei E A., Ambrosioni E, Chiariello M, Leonetti G, Mancia G, Pessina A C., Salvetti A, Trimarco B, Volpe M, Grassivaro N, Vargiu G. Left ventricular diastolic dysfunction in elderly hypertensives: Results of the APROS-diadys study. J Hypertens 2007 25 2158-2167 (Pubitemid 47476315)